• A common variant in the iron regulatory gene (Hfe) alters the metabolic and transcriptional landscape in brain regions vulnerable to neurodegeneration
• A Novel De Novo Missense Mutation in <em>KIF1A</em> Associated with Young-Onset Upper-Limb Amyotrophic Lateral Sclerosis
• A patient-derived amyotrophic lateral sclerosis blood-brain barrier model for focused ultrasound-mediated anti-TDP-43 antibody delivery
• A rapid and easy-to-use spinal muscular atrophy screening tool based on primers with high specificity and amplification efficiency for SMN1 combined with single-stranded tag hybridization assay
• Absence of motor impairments or pathological changes in TMEM230 knockout rats
• Advance directives in amyotrophic lateral sclerosis - a systematic review and meta-analysis
• All-in-one wearable drug efficacy assessment systems for bulbar muscle function using amyotrophic lateral sclerosis animal models
• Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral Sclerosis
• Amyotrophic lateral sclerosis associated with a new pathogenic variant of the ERBB4 gene
• An Accurate and Rapidly Calibrating Speech Neuroprosthesis
• Analysis of diffusion changes in cerebral tissues of Parkinson's patients who underwent subthalamic nucleus deep brain stimulation: Correlation of improvements in motor and neuropsychiatric symptoms
• Axonopathy Underlying Amyotrophic Lateral Sclerosis: Unraveling Complex Pathways and Therapeutic Insights
• Brain-Computer Interfaces for Restoring Communication
• Brazilian version of the Hammersmith Functional Motor Scale Expanded: cross-cultural adaptation and validation
• Camptocormia in a young man with anti-GAD-seropositive stiff-person syndrome
• Central neurodegeneration in Kennedy's disease accompanies peripheral motor dysfunction
• Cerebellar nuclei cells produce distinct pathogenic spike signatures in mouse models of ataxia, dystonia, and tremor
• Chemokine CX3CL1 (Fractalkine) Signaling and Diabetic Encephalopathy
• Circulating MAIT cells in multiple sclerosis and amyotrophic lateral sclerosis
• Clinical characterization of common pathogenic variants of SOD1-ALS in Germany
• Clinically relevant mouse models of severe spinal muscular atrophy with respiratory distress type 1
• Coadministration of 6-Shogaol and Levodopa Alleviates Parkinson's Disease-Related Pathology in Mice
• Coffee and amyotrophic lateral sclerosis (ALS)
• Cognitive reserve as a modulator of cognitive decline and of behavioral symptoms in patients with amyotrophic lateral sclerosis
• Communicating the diagnosis of spinal muscular atrophy in endogamous vs. non-endogamous regions
• Correction to: Diagnostic value of neurofilaments in differentiating motor neuron disease from multifocal motor neuropathy
• Cortical inexcitability in ALS: correlating a clinical phenotype
• Cramp-Fasciculation Syndrome Associated with Natural and Added Chemicals in Popular Food Items
• D-Glutamate production by stressed Escherichia coli gives a clue for the hypothetical induction mechanism of the ALS disease
• Data and Process Harmonisation of Multi-National, Multi-Site Research Data
• Digital Biomarker for Muscle Function Assessment using Surface Electromyography with Electrical Stimulation and A Non-Invasive Wearable Device
• Dilemma in patients with amyotrophic lateral sclerosis and expectations from brain-machine interfaces
• Disturbances in Muscle Energy Metabolism in Patients with Amyotrophic Lateral Sclerosis
• Diverse Phenotypic Presentation of the Welander Distal Myopathy Founder Mutation, With Myopathy and Amyotrophic Lateral Sclerosis in the Same Family
• Dopaminergic progenitors generated by small molecule approach survived, integrated, and promoted functional recovery in (6-OHDA) mouse model of Parkinson's disease
• Dysregulation of cerebrospinal fluid metabolism profiles in spinal muscular atrophy patients: a case control study
• Electroacupuncture alleviates motor dysfunction by regulating neuromuscular junction disruption and neuronal degeneration in SOD1(G93A) mice
• Electrodiagnostic support in an atypical form of amyotrophic lateral sclerosis (Vulpian-Bernhardt syndrome)
• Emphasis on the importance of comprehensive clinical and genetic analysis - spinal muscular atrophy combined with phenylketonuria: A case report
• Excitatory to inhibitory synaptic ratios are unchanged at presymptomatic stages in multiple models of ALS
• Gait Reconstruction Strategy Using Botulinum Toxin Therapy Combined with Rehabilitation
• Generation of Human-Induced Pluripotent Stem Cells from Peripheral Blood Mononuclear Cells of C9ORF72-Associated Amyotrophic Lateral Sclerosis Patients
• Genetic Associations With an Amyotrophic Lateral Sclerosis Reversal Phenotype
• Harnessing Mirror Neurons: A New Frontier in Parkinson's Disease Rehabilitation-A Scoping Review of the Literature
• Heterozygous knockout of Synaptotagmin13 phenocopies ALS features and TP53 activation in human motor neurons
• Impact of Disease-modifying Therapies on Respiratory Function in People with Neuromuscular Disorders
• Increased copy-number variant load of associated risk genes in sporadic cases of amyotrophic lateral sclerosis
• Inflammasome-Inhibiting Nanoligomers Are Neuroprotective against Space-Induced Pathology in Healthy and Diseased Three-Dimensional Human Motor and Prefrontal Cortex Brain Organoids
• Integrated Approaches and Practical Recommendations in Patient Care Identified with 5q Spinal Muscular Atrophy through Newborn Screening
• Integrated elemental analysis supports targeting copper perturbations as a therapeutic strategy in multiple sclerosis
• Intranasal delivery of small extracellular vesicles reduces the progress of amyotrophic lateral sclerosis and the overactivation of complement-coagulation cascade and NF-ĸB signaling in SOD1^G93A mice
• Judicialization of Zolgensma in the Ministry of Health: costs and clinical profile of patients
• Learning From the Exception and Not the Rule: Genetic Associations With an Amyotrophic Lateral Sclerosis Reversal Phenotype
• Limbic Network and Papez Circuit Involvement in ALS: Imaging and Clinical Profiles in GGGGCC Hexanucleotide Carriers in <em>C9orf72</em> and <em>C9orf72</em>-Negative Patients
• Local protein synthesis at neuromuscular synapses is required for motor functions
• Longevity of a Brain-Computer Interface for Amyotrophic Lateral Sclerosis
• Loss of MEF2C function by enhancer mutation leads to neuronal mitochondria dysfunction and motor deficits in mice
• Mass spectrometry imaging of SOD1 protein-metal complexes in SOD1G93A transgenic mice implicates demetalation with pathology
• Meldonium, as a potential neuroprotective agent, promotes neuronal survival by protecting mitochondria in cerebral ischemia-reperfusion injury
• Mogroside V and mogrol: unveiling the neuroprotective and metabolic regulatory roles of Siraitia grosvenorii in Parkinson's disease
• Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation
• Monoclonal antibodies to Respiratory Syncytial Virus (RSV) in patients with Spinal Muscular Atrophy Type 1
• Palliative care needs and utilisation of specialist services for people diagnosed with motor neuron disease: a national population-based study
• Palmatine Ameliorates Motor Deficits and Dopaminergic Neuron Loss by Regulating NLRP3 Inflammasome through Mitophagy in Parkinson's Disease Model Mice
• Phagocytosis of aggrecan-positive perineuronal nets surrounding motor neurons by reactive microglia expressing MMP-9 in TDP-43(Q331K) ALS model mice
• Phenotype distinctions in mice deficient in the neuron-specific alpha3 subunit of Na,K-ATPase: Atp1a3(tm1Ling/+)and Atp1a3 (+/D801Y)
• Physiological Features of the Neural Stem Cells Obtained from an Animal Model of Spinal Muscular Atrophy and Their Response to Antioxidant Curcumin
• Plasma, brain and spinal cord concentrations of caffeine are reduced in the SOD1^G93A mouse model of amyotrophic lateral sclerosis following oral administration
• Poly-GR repeats associated with ALS/FTD gene <em>C9ORF72</em> impair translation elongation and induce a ribotoxic stress response in neurons
• Postural instability and lower extremity dysfunction in upper motor neuron-dominant amyotrophic lateral sclerosis
• Prognostic communication in amyotrophic lateral sclerosis: findings from a Nationwide Italian survey
• Pyrrole adducts mediated mitochondrial dysfunction activates SARM1-dependent axon degeneration in 2,5-hexanedione-induced neuropathy
• Quantitative Analysis of Glutathione and Carnosine Adducts with 4-Hydroxy-2-nonenal in Muscle in a hSOD1^G93A ALS Rat Model
• Rare Variants of the <em>SMN1</em> Gene Detected during Neonatal Screening
• Recognising dying in motor neurone disease: A scoping review
• Rehabilitation for spinal muscular atrophy patients in China: a national cross-sectional study
• Repetitive magnetic stimulation prevents dorsal root ganglion neuron death and enhances nerve regeneration in a sciatic nerve injury rat model
• Schwann cell JUN expression worsens motor performance in an amyotrophic lateral sclerosis mouse model
• Scientific plurality and amyotrophic lateral sclerosis (ALS): A philosophical and historical perspective on Charcot's texts
• Sensory-motor circuit is a therapeutic target for dystonia musculorum mice, a model of hereditary sensory and autonomic neuropathy 6
• SIGMAR1 targets AMPK/ULK1 pathway to inhibit SH-SY5Y cell apoptosis by regulating endoplasmic reticulum stress and autophagy
• SoDCoD: a comprehensive database of Cu/Zn superoxide dismutase conformational diversity caused by ALS-linked gene mutations and other perturbations
• Study of Language Function in Bengali-Speaking Population with Motor Neuron Disease
• Surface electromyography of the vastus lateralis and gluteus medius muscles in post-operative T3-L3 hemilaminectomy dogs: a prospective controlled observational study
• Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications
• The ALS-associated KIF5A P986L variant is not pathogenic for Drosophila motoneurons
• The burden of upper motor neuron involvement is correlated with the bilateral limb involvement interval in patients with amyotrophic lateral sclerosis: a retrospective observational study
• The effect of growth hormone on motor findings and dendrite morphology in an experimental Parkinson's disease model
• The Impact of Nusinersen and Risdiplam on Motor Function for Spinal Muscular Atrophy Type 2 and 3: A Meta-Analysis
• The integrity of the corticospinal tract and corpus callosum, and the risk of ALS: univariable and multivariable Mendelian randomization
• The molecular mechanisms that underlie IGHMBP2-related diseases
• Therapeutics Targeting Skeletal Muscle in Amyotrophic Lateral Sclerosis
• Timeline of hypoglossal motor neuron death and intrinsic tongue muscle denervation in high-copy number SOD1(G93A) mice
• Tirbanibulin (KX2-391) analog KX2-361 inhibits botulinum neurotoxin serotype A mediated SNAP-25 cleavage in pre- and post-intoxication models in cells
• Unveiling the adverse events of Nusinersen in spinal muscular atrophy management based on FAERS database
• User expectations and experiences of an assistive robotic arm in amyotrophic lateral sclerosis: a multicenter observational study
• Utility of the Repetitive Nerve Stimulation Test and Needle EMG in the Trapezius Muscle for the Early Diagnosis of ALS
• Veterans with familial ALS and bulbar and respiratory presentations at onset had shorter survival
• Visualization and Quantification of Organelle Axonal Transport in Cultured Neurons
• Watch for inclusion body myositis